Filing Details
- Accession Number:
- 0001213900-14-008549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-24 14:55:48
- Reporting Period:
- 2014-11-14
- Filing Date:
- 2014-11-24
- Accepted Time:
- 2014-11-24 14:55:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1525354 | Martin Shkreli | 101 Avenue Of The Americas, 9Th Floor New York NY 10013 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-11-14 | 100,000 | $10.23 | 2,837,168 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-17 | 100,000 | $9.41 | 2,737,168 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-18 | 254,975 | $9.19 | 2,482,193 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-19 | 329,824 | $8.54 | 2,152,369 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-20 | 134,354 | $8.23 | 2,018,015 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-21 | 252,847 | $8.41 | 1,765,168 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Prepaid Forward Contract (obligation to sell) | Acquisiton | 2014-09-09 | 123,000 | $0.00 | 123,000 | $0.00 |
Common Stock | Prepaid Forward Contract (obligation to sell) | Acquisiton | 2014-09-12 | 205,000 | $0.00 | 205,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
123,000 | 2016-09-12 | 2016-09-14 | Yes | 4 | J | Direct |
205,000 | 2016-09-15 | 2016-09-21 | Yes | 4 | J | Direct |
Footnotes
- On September 9, 2014, the reporting person entered into a prepaid forward contract with an unaffiliated third party buyer. The contract obligates the reporting person to deliver to the buyer, at the reporting person's option, up to 123,000 shares of common stock, par value $0.0001 per share ("Common Stock"), of Retrophin, Inc., cash or a combination thereof on the maturity date of the contract (September 14, 2016). In exchange for assuming this obligation, the reporting person received a cash payment of $1,069,166 as of the date of entering into the contract. The reporting person pledged 123,000 shares of Common Stock (the "September 9 Pledged Shares") to secure his obligations under such contract and retained voting rights in the September 9 Pledged Shares during the term of the pledge.
- On September 12, 2014, the reporting person entered into a prepaid forward contract with an unaffiliated third party buyer. The contract obligates the reporting person to deliver to the buyer, at the reporting person's option, up to 205,000 shares of Common Stock, cash or a combination thereof on the maturity date of the contract (September 21, 2016). In exchange for assuming this obligation, the reporting person received a cash payment of $1,789,679 as of the date of entering into the contract. The reporting person pledged 205,000 shares of Common Stock (the "September 12 Pledged Shares") to secure his obligations under such contract and retained voting rights in the September 12 Pledged Shares during the term of the pledge.